معرفی
Ritu Chakravarti, PhD, is an Associate Professor in the Department of Internal Medicine at the University of Kentucky College of Medicine, with additional affiliations in Rheumatology and the Department of Microbiology, Immunology & Molecular Genetics.
Education:
- Doctor of Philosophy: Indian Institute of Technology, Delhi
- Master of Science: Devi Ahilya Vishwavidyalaya, Indore, India
- Bachelor of Arts: University of Delhi
Her research focuses on understanding the molecular mechanisms underlying autoimmune and inflammatory diseases, particularly rheumatoid arthritis and inflammation-induced bone loss. She investigates the dual role of the 14-3-3zeta protein as both a signaling adaptor and a self-antigen, exploring its potential as a therapeutic target. Her lab has demonstrated that immunization targeting 14-3-3zeta can delay arthritis onset and reduce joint inflammation in animal models, with concomitant anabolic effects on bone.
Dr. Chakravarti's work bridges immunology, molecular genetics, and translational medicine, aiming to advance novel immunomodulatory strategies toward pre-clinical development. Although specific publications are listed on PubMed, no article titles were provided in the source text, so trends cannot be detailed further.
Scientific Awards:
Dr. Chakravarti leads an active research laboratory focused on autoimmunity and 14-3-3 proteins. She mentors research within her lab and collaborates across disciplines, though no formal advisees or grant funding details are mentioned in the available information.
Laboratory and Team:
The Chakravarti Lab conducts research on autoimmune mechanisms and therapeutic interventions, with a strong emphasis on molecular immunology and bone biology.
